loadpatents
name:-0.049986124038696
name:-0.048120021820068
name:-0.0036990642547607
Aberg; A. K. Gunnar Patent Filings

Aberg; A. K. Gunnar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aberg; A. K. Gunnar.The latest application filed is for "methods of treatment of inflammatory cytokine-related arthritic disorders".

Company Profile
3.47.48
  • Aberg; A. K. Gunnar - Sarasota FL
  • Aberg; A. K. Gunnar - Westborough MA
  • Aberg; A. K. Gunnar - Lawrenceville NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods of treatment of asthma and COPD
Grant 11,197,851 - Aberg , et al. December 14, 2
2021-12-14
Methods Of Treatment Of Inflammatory Cytokine-related Arthritic Disorders
App 20210267960 - Aberg; A.K. Gunnar ;   et al.
2021-09-02
Methods Of Treatment Of Asthma And Copd
App 20210186945 - Aberg; A.K. Gunnar ;   et al.
2021-06-24
Methods of treatment of asthma and COPD
Grant 10,959,992 - Aberg , et al. March 30, 2
2021-03-30
Methods Of Treatment Of Asthma And Copd
App 20200352927 - Aberg; A.K. Gunnar ;   et al.
2020-11-12
Methods Of Treatment Of Respiratory Disorders
App 20200268734 - Aberg; A.K. Gunnar ;   et al.
2020-08-27
Medicinal Treatment of Chronic Inflammatory Dermal Disorders
App 20180344721 - Aberg; A.K. Gunnar ;   et al.
2018-12-06
Medicinal treatment of dermal infectious disorders with norketotifen
Grant 9,808,419 - Aberg , et al. November 7, 2
2017-11-07
Formulations and methods for treating high intraocular pressure
Grant 9,694,003 - Aberg , et al. July 4, 2
2017-07-04
Formulations and Methods for Treating High Intraocular Pressure
App 20170105987 - Aberg; A.K. Gunnar ;   et al.
2017-04-20
Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients
Grant 9,439,895 - Aberg , et al. September 13, 2
2016-09-13
Methods Of Treating Pruritic Conditions Mediated Through Non-histaminergic Mechanisms In Diabetic Patients
App 20160228426 - Aberg; A.K. Gunnar ;   et al.
2016-08-11
Medicinal Treatment Of Dermal Infectious Disorders With Norketotifen
App 20160193143 - ABERG; A. K. GUNNAR ;   et al.
2016-07-07
Methods of treatment of non-histaminic pruritus
Grant 9,345,697 - Aberg , et al. May 24, 2
2016-05-24
Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disorders
Grant 9,333,199 - Aberg , et al. May 10, 2
2016-05-10
Methods Of Treatment Of Histamine H-4 Receptor-related Pruritus Associated With Nerve Disorders
App 20150342944 - Aberg; A.K. Gunnar ;   et al.
2015-12-03
Methods Of Treatment Of Non-histaminic Pruritus
App 20150272942 - Aberg; A.K. Gunnar ;   et al.
2015-10-01
Medicinal Treatment Of Chronic Pulmonary Inflammatory Diseases With Norketotifen
App 20150272941 - Aberg; A. K. Gunnar ;   et al.
2015-10-01
Methods of treatment of histamine H-4 receptor-related pruritus
Grant 9,138,431 - Aberg , et al. September 22, 2
2015-09-22
Ocular formulations of norketotifen
Grant 8,969,385 - Aberg , et al. March 3, 2
2015-03-03
Methods Of Treating Pruritic Conditions Mediated Through Histamine H-4 Receptors
App 20150045392 - Aberg; A.K. Gunnar ;   et al.
2015-02-12
Ocular Formulations Of Norketotifen
App 20140303091 - Aberg; A.K. Gunnar ;   et al.
2014-10-09
Medicinal treatment of dermal diseases in companion animals
Grant 8,778,971 - Aberg , et al. July 15, 2
2014-07-15
Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen
Grant 8,765,787 - Aberg , et al. July 1, 2
2014-07-01
Treating xerophthalmia with norketotifen
Grant 8,741,930 - Aberg , et al. June 3, 2
2014-06-03
Medicinal Treatment Of Atopic Inflammatory Diseases
App 20140120121 - Aberg; A.K. Gunnar ;   et al.
2014-05-01
Medicinal Treatment Of Dermal Diseases In Companion Animals
App 20140113936 - Aberg; A.K. Gunnar ;   et al.
2014-04-24
Medicinal treatment of dermal diseases in dogs
Grant 8,557,846 - Aberg , et al. October 15, 2
2013-10-15
Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals
Grant 8,445,542 - Aberg May 21, 2
2013-05-21
Methods Of Accelerating Muscle Growth, Decreasing Fat Deposits And Improving Feed Efficiency In Livestock Animals
App 20130090295 - Aberg; A.K. Gunnar
2013-04-11
Use of RR/SR-ractopamine
Grant 8,383,685 - Aberg February 26, 2
2013-02-26
Method Of Accelerating Muscle Growth, Decreasing Fat Deposits And Improving Feed Efficiency In Livestock Animals
App 20120065271 - Aberg; A.K. Gunnar
2012-03-15
Use Of RR/SR-Ractopamine
App 20120015895 - Aberg; A.K.Gunnar
2012-01-19
Use of RR/SR-ractopamine
Grant 8,071,653 - Aberg , et al. December 6, 2
2011-12-06
Treating Xerophthalmia With Compounds Increasing Meibomian Gland Secretion
App 20110294897 - Aberg; A.K. Gunnar ;   et al.
2011-12-01
Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain
App 20110218218 - Aberg; A.K. Gunnar ;   et al.
2011-09-08
Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals
Grant 7,985,775 - Aberg July 26, 2
2011-07-26
Optically active isomers of ketotifen and therapeutically active metabolites thereof
Grant 7,872,025 - Aberg , et al. January 18, 2
2011-01-18
Use Of RR/SR-Ractopamine
App 20100184865 - Aberg; A.K. Gunnar ;   et al.
2010-07-22
Ocular Formulations Of Norketotifen
App 20100130550 - Aberg; A.K. Gunnar ;   et al.
2010-05-27
Use of RR/SR-ractopamine
Grant 7,723,392 - Aberg , et al. May 25, 2
2010-05-25
Treatment xerophthalmia with norketotifen
App 20100105734 - Aberg; A.K. Gunnar ;   et al.
2010-04-29
Dermal Compositions Of Substituted Amides And The Use Thereof As Medication For Pain And Pruritus
App 20100041704 - Aberg; A.K. Gunnar ;   et al.
2010-02-18
Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
Grant 7,592,458 - Wright , et al. September 22, 2
2009-09-22
Optically active isomers of ketotifen and therapeutically active metabolites thereof
Grant 7,557,128 - Aberg , et al. July 7, 2
2009-07-07
Optically active isomers of ketotifen and therapeutically active metabolites thereof
App 20090149502 - Aberg; A. K. Gunnar ;   et al.
2009-06-11
Use of RR/SR-ractopamine
App 20090143480 - Aberg; A.K. Gunnar ;   et al.
2009-06-04
Formulations of Indanylamines and the Use Thereof as Local Anesthetics and as Medication for Chronic Pain
App 20090137628 - Aberg; A.K. Gunnar ;   et al.
2009-05-28
Synergisms between repartitioning and immunomodulating compounds
App 20090054338 - Aberg; A.K. Gunnar
2009-02-26
Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock Animals
App 20090004235 - Aberg; A.K. Gunnar
2009-01-01
Optically active isomers of ketotifen and therapeutically active metabolites thereof
App 20080287498 - Aberg; A.K. Gunnar ;   et al.
2008-11-20
Methods for treating urinary incontinence in patients suffering from memory disorders
Grant 7,390,816 - Aberg June 24, 2
2008-06-24
Dermal anesthetic compounds
App 20080033052 - Wright; George E. ;   et al.
2008-02-07
Method Of Decreasing Fat Deposits And Body Weight In Mammals And Birds
App 20080020019 - Aberg; A.K. Gunnar
2008-01-24
Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock Animals
App 20070282010 - Aberg; A.K. Gunnar
2007-12-06
Optically active isomers of ketotifen and therapeutically active metabolites thereof
Grant 7,226,934 - Aberg , et al. June 5, 2
2007-06-05
Compositions of descarboethoxyloratadine
Grant 7,214,683 - Aberg , et al. May 8, 2
2007-05-08
Methods for the treatment of allergic rhinitis
Grant 7,214,684 - Aberg , et al. May 8, 2
2007-05-08
Methods for treating urticaria using descarboethoxyloratadine
Grant 7,211,582 - Aberg , et al. May 1, 2
2007-05-01
Methods for relaxation of smooth muscle contractions using Trospium
App 20070004766 - Aberg; A.K. Gunnar
2007-01-04
Methods for treating smooth muscle contractions using trospium
App 20060293356 - Aberg; A.K. Gunnar
2006-12-28
Methods for treating smooth muscle disorders using trospium
App 20060287347 - Aberg; A.K. Gunnar
2006-12-21
Smooth muscle spasmolytic agents
Grant 7,141,696 - Aberg , et al. November 28, 2
2006-11-28
Methods for treating urinary incontinence and other disorders using trospium
Grant 6,974,820 - Aberg December 13, 2
2005-12-13
Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
App 20050131046 - Aberg, A.K. Gunnar ;   et al.
2005-06-16
Method of decreasing fat deposits and body weight in mammals and birds
App 20050113456 - Aberg, A.K. Gunnar
2005-05-26
Methods for treating urinary incontinence and other disorders using trospium
App 20050043342 - Aberg, A.K. Gunnar
2005-02-24
Smooth muscle spasmolytic agents
App 20040248987 - Aberg, A.K. Gunnar ;   et al.
2004-12-09
Galenical preparations of dapsone and related sulphones, and method of therapeutic and preventative treatment of disease
App 20030092635 - Aberg, A K Gunnar ;   et al.
2003-05-15
Tolterodine metabolites
App 20030027856 - Aberg, A.K. Gunnar
2003-02-06
Methods for treating disorders using norastemizole in combination with other active ingredients
App 20020137768 - Woosley, Raymond L. ;   et al.
2002-09-26
Non-arrhythmogenic metabolite of oxybutynin
Grant 6,432,446 - Aberg August 13, 2
2002-08-13
Dermal anesthetic agents
Grant 6,413,987 - Aberg , et al. July 2, 2
2002-07-02
Methods and compositions for treating infection using optically pure (S) -lomefloxacin
App 20020061894 - Young, James W. ;   et al.
2002-05-23
Non-arrhythmogenic metabolite of oxybutynin
App 20020002201 - Aberg, A.K. Gunnar
2002-01-03
Compositions For Treating Alergic And Other Disorders Using Norastemizole In Combination With Other Active Ingredients
App 20010053787 - Woosley, Raymond L. ;   et al.
2001-12-20
Methods and compositions for treating infection using optically pure (S)-lomefloxacin
App 20010012842 - Young, James W. ;   et al.
2001-08-09
Benzocycloheptathiophene compounds
Grant 6,207,683 - Aberg , et al. March 27, 2
2001-03-27
Smooth muscle spasmolytic agents, compositions and methods of use thereof
Grant 6,207,852 - Aberg , et al. March 27, 2
2001-03-27
Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
Grant 6,207,684 - Aberg March 27, 2
2001-03-27
Methods and compositions for treating allergic disorders and other disorders using metabolic derivatives of astemizole
Grant 6,130,233 - Woosley , et al. October 10, 2
2000-10-10
Treating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutynin
Grant 6,123,961 - Aberg September 26, 2
2000-09-26
Methods of accelerating muscle growth and improving feed efficiency in animals by using optically pure eutomers of adrenergic beta-2 receptor agonists, and food supplements containing the same
Grant 6,110,974 - Aberg , et al. August 29, 2
2000-08-29
Methods for treating infection using optically pure (S)-lomefloxacin
Grant 6,075,024 - Young , et al. June 13, 2
2000-06-13
Methods for treating central nervous system disorders and other disorders using optically pure (-) norcisapride
Grant 5,877,189 - McCullough , et al. March 2, 1
1999-03-02
Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
Grant 5,712,293 - McCullough , et al. January 27, 1
1998-01-27
Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromboxane A.sub.2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation
Grant 5,312,818 - Rubin , et al. May 17, 1
1994-05-17
Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
Grant 5,262,419 - Aberg , et al. November 16, 1
1993-11-16
Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
Grant 5,166,143 - Ondetti , et al. November 24, 1
1992-11-24
Method for lowering serum cholesterol employing a phosphorus containing ACE inhibitor alone or in combination with a cholesterol lowering drug
Grant 5,157,025 - Aberg , et al. October 20, 1
1992-10-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed